Selected Safety Information
- The NEXPLANON implant should be removed if blood pressure rises significantly and becomes uncontrolled.
- Studies suggest a small increased relative risk of developing gallbladder disease among combination hormonal contraceptive users. It is not known whether a similar risk exists with progestin-only methods like NEXPLANON.
Palpate after insertion
NEXPLANON (etonogestrel implant) 68 mg should be inserted subdermally in the arm
Always verify the presence of the implant in the woman’s arm immediately after insertion by palpation
- The patient should also be able to palpate the implant
If the implant is not palpable or there is doubt about its presence, check the applicator and use 1 of the 4 available methods to confirm its presence
Until the presence of the implant has been verified, the woman should be advised to use a nonhormonal contraceptive method, such as condoms
Palpate before removal
The exact location of the implant in the arm should be verified by palpation before removal procedure
A nonpalpable implant should always be first located prior to removal using 1 of the 4 available localization methods
The NEXPLANON implant is radiopaque, providing 4 methods for confirming the presence after insertion and localizing before removal:
Computed tomography (CT) scan
Magnetic resonance imaging (MRI)